HCG Q1 revenue at Rs 326.58 cr. 67 per cent increase YoY
Substantial reduction in losses
Substantial reduction in losses
The Union Budget makes a clear and timely choice by placing biopharma at the centre of India’s next manufacturing wave
The surgical team used LD Flap Reconstruction, a specialised technique that rebuilt elbow strength and movement
The new facility combines advanced technology, enhanced capacity, and holistic care, reaffirming HCG’s commitment to accessible, world-class oncology in Gujarat
The Union Budget 2025-26 strengthens India's healthcare sector with an allocation of Rs. 99,858.56 crore, marking a 9.78% rise from Rs. 90,958.63 crore in 2024-25
Expand the scope of the Production-Linked Incentive (PLI) scheme and increase its allocation to cover more pharmaceutical products and raw materials
Our centers are performing as expected or even better
Marks the World Head & Neck Cancer Day at the OCTF Conference
Subscribe To Our Newsletter & Stay Updated